Skip to main content
. 2009 Apr;13(1):33–37. doi: 10.4103/0019-5278.50722

Table 3.

Comparison of mean blood levels in ppb of polycyclic aromatic hydrocarbons of cases and controls

Polycyclic aromatic hydrocarbons Cases (n = 42) Control (n = 20) t-test, P-value


n, % Mean ± SD (min.–max.) n, % Mean ± SD (min.–max.)
Napthalene 21 (50.0) 69.90 ± 105.81 (0–432) 11 (55.0) 110.8 ± 244.22 (0–1099) 0.14, 0.35
Acenapthene 22 (52.4) 147.16 ± 246.112 (0–958) 6 (30.0) 326.1 ± 861.99 (0–3064) 1.25, 0.215
Phenanthrene 29 (69.0) 63.11 ± 115.621 (0–524.82) 20 (15.0) 4.20 ± 10.68 (0–34.15) 2.26, 0.027
Anthracene 24 (57.1) 3.002 ± 5.471 (2–26.53) 0 (0)
Fluoranthene 20 (47.6) 16.90 ± 27.230 (0–89) 8 (40.8) 38.2 ± 82.47 (0–330) 152, 0.13
Pyrene 19 (45.2) 22.56 ± 49.643 (0–278.28) 5 (25.0) 41.58 ± 153.32 (0–689.86) 0.73, 0.47
Benzo(b)fluo. 7 (16.7) 2.08 ± 5.791 (0–26) 0 (0)
Benzo(k)fluo. 4 (9.5) 26.75 ± 104.071 (0–483.20) 0 (0)
Benzo(a) pyrene 4 (9.5) 0.32 ± 1.137 (0–5) 2 (10.0) 0.45 ± 1.40 (0–5) 0.42, 0.68
Di benz (a,h) 1 (2.4) 0.45 ± 2.920 (0–19) 0 (0)

Ppb, parts per billion.